克拉里思罗米调节了由人类呼吸道上皮细胞中Prevotella intermedia诱导的中性质炎症
Naoki Iwanaga1, Ayaka Ota2, Hiroki Ashizawa1,3
1Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Antibiotics (Basel, Switzerland)
|September 28, 2024
概括
牙周病原体Prevotella intermedia通过ERK1/2信号触发中性恋炎症. 像克拉里胺素这样的宏类药物抑制了这种反应,这表明肺炎的治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牙周病原体,如Prevotella intermedia,与严重的中性恋炎症有关.
- 精确的机制和宏类药物在P. intermedia引起的炎症中的有效性仍然不清楚.
研究的目的:
- 为了阐明P.介质诱导的中性恋炎症的信号通路.
- 评估宏类物质在缓解这种炎症方面的治疗潜力.
主要方法:
- 人类呼吸道上皮细胞NCl-H292用P.中介性上游生物和克拉里菌素进行了治疗.
- 测量了CXCL8转录和IL-8的产生.
- 分析了使用抑制剂和西方涂抹的MAPK信号通路.
主要成果:
- P. 介质上游生物显著增加了CXCL8和IL-8的产生.
- 克拉里思罗米辛治疗前抑制了这些增加.
- 细胞外信号调节激酶 (ERK) 1/2酸化被确定为一个关键的调解剂,被克拉里胺抑制.
结论:
- P.intermedia通过ERK1/2通道诱导空气道上皮细胞产生IL-8.
- 麦克罗利德在调节牙周病原体诱导的肺炎方面显示出潜在的潜力.
更多相关视频
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
8.8K
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
2.7K
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
358
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
